Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA04
- Pharmacological subgroupA04A
- Chemical subgroupA04ADOther antiemetics
- Chemical substanceA04AD11Nabilone
Where it is registered
Each register and historical list with its number of registrations and a few of them.
At a glance
- ATC code
- A04AD11
- ATC group
- Alimentary tract and metabolism
- Registers
- 2
- Registrations
- 18
- With their own page
- 13
- Companies
- 6
All medicines with Nabilone
Human medicines from every register that match Nabilone by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
18 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| PMS-Nabilone | Canada | 1.0 MG | Capsule | Marketed | Pharmascience INC |
| PMS-Nabilone | Canada | 0.5 MG | Capsule | Marketed | Pharmascience INC |
| PMS-Nabilone | Canada | 0.25 MG | Capsule | Marketed | Pharmascience INC |
| Teva-Nabilone | Canada | 1.0 MG | Capsule | Marketed | Teva Canada Limited |
| Teva-Nabilone | Canada | 0.25 MG | Capsule | Marketed | Teva Canada Limited |
| Teva-Nabilone | Canada | 0.5 MG | Capsule | Marketed | Teva Canada Limited |
| Apo-Nabilone | Canada | 0.25 MG | Capsule | Authorised | Apotex INC |
| Apo-Nabilone | Canada | 0.5 MG | Capsule | Authorised | Apotex INC |
| Apo-Nabilone | Canada | 1 MG | Capsule | Authorised | Apotex INC |
| Cesamet | United States | 1MG | capsule | Not marketed | Bausch |
| Cesamet | Canada | 0.25 MG | Capsule | Marketed | Bausch Health, Canada INC. |
| Cesamet | Canada | 0.5 MG | Capsule | Marketed | Bausch Health, Canada INC. |
| Cesamet | Canada | 1 MG | Capsule | Marketed | Bausch Health, Canada INC. |
| Act Nabilone | Canada | 1 MG | Capsule | Cancelled | Teva Canada Limited |
| Act Nabilone | Canada | 0.5 MG | Capsule | Cancelled | Teva Canada Limited |
| Ran-Nabilone | Canada | 0.5 MG | Capsule | Cancelled | Ranbaxy Pharmaceuticals Canada INC. |
| Ran-Nabilone | Canada | 0.25 MG | Capsule | Cancelled | Ranbaxy Pharmaceuticals Canada INC. |
| Ran-Nabilone | Canada | 1 MG | Capsule | Cancelled | Ranbaxy Pharmaceuticals Canada INC. |